By staff writers

December 6, 2012 -- CoreLab Partners has launched a new imaging service targeting the utilization of independent central image review in the detection of early Alzheimer's disease.

Michael Woehler, PhD, CoreLab's president and CEO, said that with the evolution of MRI, PET, and SPECT imaging in dementia-related clinical trials, the company wants to form a team of healthcare professionals with enhanced technological tools to better assess those images.

Copyright © 2012

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking